Vortex “As a clinician, I am excited about accessing the cancer biology of patient’s through CTCs. Vortex’s technology provides the best source of CTCs to aid in the diagnostic and treatment decisions we face every day.” – Dr. Jonathan Goldman, MD, Director of Clinical Trials in Thoracic Oncology, Associate Director of Drug Development at UCLA “Improving CTCs recovery along with high cellular purity while maintaining viability have tremendous value for translational research and clinical diagnostic applications. The VTX-1 holds the potential to revolutionize blood-based diagnostics.” - Pr. Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine Wanda J. Cribbs, Lead Gartner Analyst Population Health & Analytics says: "Wanda's recent HRS press release really stands out. Delivering those results and having a client publicly share credit with their vendor is rare and says a lot. We at Gartner will have our eyes on Wanda in 2018"

NetScientific is a transatlantic healthcare IP commercialisation group.
We fund and develop companies that significantly improve the health and well-being of people with chronic diseases.

OUR TEAM

Sector-specialist senior management team with extensive commercial experience.

  • Sir Richard Sykes, FRS

    Sir Richard Sykes, Non-Executive Chairman of the Group, joined NetScientific in 2008. Sir Richard spent thirty years working in the biotechnology and pharmaceutical industries, …

    Chairman
  • Ian Postlethwaite

    Ian Postlethwaite, Chief Executive Office, Chief Financial Officer & Company Secretary, joined NetScientific in June 2016. He brings over 14 years of biopharma experience …

    Chief Executive Officer, Chief Financial Officer & Company Secretary

NEWS

NetScientific plc (“NetScientific” or the “Company” or the “Group”)     Notice of AGM and Annual Report & Accounts   London, UK – 24 May 2019 – NetScientific …

NetScientific plc   (“NetScientific” or the “Group”)   NetScientific Full Year Results for the year ended 31 December 2018   London, UK – 22 May 2019 – NetScientific …

16 May 2019 NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology journal publication   NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its …

NetScientific healthcare technology group